Who validates what
Under 21 CFR Part 11, EU GMP Annex 11 and GAMP 5, validation is the regulated company’s responsibility: you define what the system must do for your process, assess the risk, and test proportionately. The supplier’s job is to build the system under control, provide the technical controls the regulations expect, and support your validation with evidence and expertise. Swat iQua Suite is designed around that split.
From scripted testing to assurance
Traditional CSV often meant exhaustive scripted protocols for every screen. FDA’s computer software assurance approach and GAMP 5 second edition both encourage critical thinking instead: establish the intended use, decide which functions directly affect product quality, patient safety or data integrity, and focus documented testing there — using lighter, unscripted testing where the risk is lower.
A typical risk-based lifecycle
- Intended use and user requirements — what your processes need the system to do
- Risk assessment — which requirements touch product quality, patient safety or data integrity
- Configuration — sites, roles, workflows and masters set up and recorded
- Verification — testing proportionate to risk, with evidence traced to each requirement
- Release and periodic review — go-live sign-off, then change control, audit-trail review and periodic evaluation
Installation, operational and performance qualification (IQ, OQ and PQ) remain familiar milestones in many quality systems. Whether you keep that structure or move to a CSA-style approach, the evidence still needs to trace back to approved requirements — which is what the register is for.
Swat iQua Suite is designed to support a GAMP 5 risk-based validation approach. Validation of each installation remains the regulated company’s responsibility.
